Background. Few data with adequate evidence exists as regards the effect of Cyclosporine (CsA) and mycophenolate mofetil (MMF) on pathological prognostic parameters in patients with steroid resistant focal segmental glomerulosclerosis (FSGS). The purpose of the present study is to compare the effect of cyclosporin and mycophenolate mofetil in addition to steroids on functional and histopathologic renal parameters in patients with steroid resistant FSGS one year after treatment
To determine the prognostic value of response to treatment in patients with focal segmental glomerul...
Optimal therapy of patients with steroid-resistant primary focal segmental glomerulosclerosis (FSGS)...
Adult primary focal segmental glomerulosclerosis (FSGS) remains a therapeutic challenge for the trea...
Idiopathic focal segmental glomerulosclerosis (FSGS) is among the most common, morbid and treatment-...
Patients with steroid-resistant focal segmental glomerulosclerosis (FSGS) may benefit from treatment...
We report our experience in using mycophenolate mofetil (MMF) for the treatment of steroid-resistant...
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomeruloscler...
This NIH-funded multicenter randomized study of focal segmental glomerulosclerosis (FSGS) treatment ...
Background A clinical trial of cyclosporine in patients with steroid-resistant focal segmental glome...
The clinical course of a young female patient with focal segmental glomerulosclerosis (FSGS) who fai...
Abstract- To determine the prognostic value of response to treatment in patients with focal segmenta...
This NIH-funded multicenter randomized study of focal segmental glomerulosclerosis (FSGS) treatment ...
Optimal therapy of patients with steroid-resistant primary focal segmental glomerulosclerosis (FSGS)...
One of the most prognostically unfavorable variants of glomerulopathy is focal segmental glomerulosc...
mycophenolate, randomized clinical trials Idiopathic focal segmental glomerulosclerosis (FSGS) is am...
To determine the prognostic value of response to treatment in patients with focal segmental glomerul...
Optimal therapy of patients with steroid-resistant primary focal segmental glomerulosclerosis (FSGS)...
Adult primary focal segmental glomerulosclerosis (FSGS) remains a therapeutic challenge for the trea...
Idiopathic focal segmental glomerulosclerosis (FSGS) is among the most common, morbid and treatment-...
Patients with steroid-resistant focal segmental glomerulosclerosis (FSGS) may benefit from treatment...
We report our experience in using mycophenolate mofetil (MMF) for the treatment of steroid-resistant...
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomeruloscler...
This NIH-funded multicenter randomized study of focal segmental glomerulosclerosis (FSGS) treatment ...
Background A clinical trial of cyclosporine in patients with steroid-resistant focal segmental glome...
The clinical course of a young female patient with focal segmental glomerulosclerosis (FSGS) who fai...
Abstract- To determine the prognostic value of response to treatment in patients with focal segmenta...
This NIH-funded multicenter randomized study of focal segmental glomerulosclerosis (FSGS) treatment ...
Optimal therapy of patients with steroid-resistant primary focal segmental glomerulosclerosis (FSGS)...
One of the most prognostically unfavorable variants of glomerulopathy is focal segmental glomerulosc...
mycophenolate, randomized clinical trials Idiopathic focal segmental glomerulosclerosis (FSGS) is am...
To determine the prognostic value of response to treatment in patients with focal segmental glomerul...
Optimal therapy of patients with steroid-resistant primary focal segmental glomerulosclerosis (FSGS)...
Adult primary focal segmental glomerulosclerosis (FSGS) remains a therapeutic challenge for the trea...